288 related articles for article (PubMed ID: 18689907)
21. Clinical characteristics and histopathological findings in 120 IgA nephropathy patients in Thailand.
Riansuwan T; Kanjanabuch T; Lewsuwan S; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S163-7. PubMed ID: 17044469
[TBL] [Abstract][Full Text] [Related]
22. [Renal vascular lesions and the occurrence of hypertension in patients with IgA nephropathy].
Boulahrouz R; Stanescu C; Charasse C; Ang KS; Le Cacheux P; Leonetti F; Rioux N; Ramee MP; Simon P
Arch Mal Coeur Vaiss; 2004; 97(7-8):782-5. PubMed ID: 15506066
[TBL] [Abstract][Full Text] [Related]
23. [Importance of the duration from the onset of a urinary abnormality until a biopsy is performed: a multivariate analysis on the application of renal biopsy for patients with IgA nephropathy].
Kiyoshi Y; Hisano S; Takebayashi S
Nihon Jinzo Gakkai Shi; 1998 Sep; 40(7):547-54. PubMed ID: 9805921
[TBL] [Abstract][Full Text] [Related]
24. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
[TBL] [Abstract][Full Text] [Related]
25. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
[TBL] [Abstract][Full Text] [Related]
26. Primary IgA nephropathy with low histologic grade and disease progression: is there a "point of no return"?
Lai FM; Szeto CC; Choi PC; Li PK; Tang NL; Chow KM; Lui SF; Wong TY; Ho KK; To KF
Am J Kidney Dis; 2002 Feb; 39(2):401-6. PubMed ID: 11840383
[TBL] [Abstract][Full Text] [Related]
27. [IgA nephropathy in patients above 45 years of age. Clinical and morphologic analysis].
Wagrowska-Danilewicz M; Danilewicz M; Szemraj M
Pol Merkur Lekarski; 1997 Sep; 3(15):115-8. PubMed ID: 9461706
[TBL] [Abstract][Full Text] [Related]
28. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
[TBL] [Abstract][Full Text] [Related]
29. Does pregnancy influence the course of IgA nephropathy? Proposal for an observational study.
Pozzi C; Limardo M;
J Nephrol; 2006; 19(2):192-5. PubMed ID: 16736419
[TBL] [Abstract][Full Text] [Related]
30. Association of MEGSIN 2093C-2180T haplotype at the 3' untranslated region with disease severity and progression of IgA nephropathy.
Xia Y; Li Y; Du Y; Yang N; Li C; Leung JC; Lam MF; Huang W; Chen S; Maxwell PH; Lai KN; Wang Y
Nephrol Dial Transplant; 2006 Jun; 21(6):1570-4. PubMed ID: 16431886
[TBL] [Abstract][Full Text] [Related]
31. Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria.
Suzuki S; Joh K
Clin Exp Nephrol; 2004 Jun; 8(2):109-16. PubMed ID: 15235927
[TBL] [Abstract][Full Text] [Related]
32. A validated model of disease progression in IgA nephropathy.
Magistroni R; Furci L; Leonelli M; Masellis M; Ligabue G; Lucchi L; Lupo A; Brezzi B; Gambaro G; Manganelli L; Pedrazzi G; Ricardi M; Bormioli L; Albertazzi A
J Nephrol; 2006; 19(1):32-40. PubMed ID: 16523423
[TBL] [Abstract][Full Text] [Related]
33. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
[TBL] [Abstract][Full Text] [Related]
34. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
Wakai K; Kawamura T; Endoh M; Kojima M; Tomino Y; Tamakoshi A; Ohno Y; Inaba Y; Sakai H
Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and implications of isolated microscopic hematuria in asymptomatic Chinese pregnant women.
Szeto CC; To KF; Lai FM; Chow KM; Tam WH; Chung KY; Leung CB; Lui SF; Li PK; Lau TK
Nephron Clin Pract; 2007; 105(4):c147-52. PubMed ID: 17259739
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of 94 cases of IgA nephropathy in children].
Mao HX; Yi ZW; Liang L; He YW; Dang XQ; Wu XC; He XJ; Mo SH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):174-8. PubMed ID: 17344613
[TBL] [Abstract][Full Text] [Related]
37. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
Stangou M; Alexopoulos E; Papagianni A; Pantzaki A; Bantis C; Dovas S; Economidou D; Leontsini M; Memmos D
Nephrology (Carlton); 2009 Sep; 14(6):613-20. PubMed ID: 19143943
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory markers and the progression of IgA glomerulonephritis.
Kaartinen K; Syrjänen J; Pörsti I; Hurme M; Harmoinen A; Pasternack A; Huhtala H; Mustonen J
Nephrol Dial Transplant; 2008 Apr; 23(4):1285-90. PubMed ID: 17986475
[TBL] [Abstract][Full Text] [Related]
39. Thin basement membrane disease in patients with familial IgA nephropathy.
Frascá GM; Soverini L; Gharavi AG; Lifton RP; Canova C; Preda P; Vangelista A; Stefoni S
J Nephrol; 2004; 17(6):778-85. PubMed ID: 15593051
[TBL] [Abstract][Full Text] [Related]
40. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
Ikee R; Kobayashi S; Saigusa T; Namikoshi T; Yamada M; Hemmi N; Imakiire T; Kikuchi Y; Suzuki S; Miura S
Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
